Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHICAGO: Pioglitazone vs Glimepiride in Type 2 Diabetes
NCT00225264Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2003
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Oct 2003; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00225264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225264.